Peer Review reports
From: ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines
| Original Submission | ||
|---|---|---|
| 19 Nov 2018 | Submitted | Original manuscript |
| 28 Nov 2018 | Author responded | Author comments - Norio Takei |
| Resubmission - Version 2 | ||
| 28 Nov 2018 | Submitted | Manuscript version 2 |
| 30 Jan 2019 | Reviewed | Reviewer Report - Richard Hill |
| 1 Mar 2019 | Reviewed | Reviewer Report - Carine Michiels |
| 10 Apr 2019 | Author responded | Author comments - Norio Takei |
| Resubmission - Version 3 | ||
| 10 Apr 2019 | Submitted | Manuscript version 3 |
| 22 Apr 2019 | Reviewed | Reviewer Report - Richard Hill |
| 1 May 2019 | Reviewed | Reviewer Report - Carine Michiels |
| 13 May 2019 | Author responded | Author comments - Norio Takei |
| Resubmission - Version 4 | ||
| 13 May 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 16 May 2019 | Editorially accepted | |
| 29 May 2019 | Article published | 10.1186/s12885-019-5727-9 |
You can find further information about peer review here.